These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25289927)

  • 1. [Closed-Loop at night for the treatment of type 1 diabetes].
    Danne T; Kordonouri O
    Dtsch Med Wochenschr; 2014 Oct; 139(42):2156. PubMed ID: 25289927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.
    Danne T; Tsioli C; Kordonouri O; Blaesig S; Remus K; Roy A; Keenan B; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2014 Jun; 16(6):338-47. PubMed ID: 24447074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial pancreas: fuzzy logic and control of glycemia.
    Nimri R; Phillip M
    Curr Opin Endocrinol Diabetes Obes; 2014 Aug; 21(4):251-6. PubMed ID: 24937038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety auxiliary feedback element for the artificial pancreas in type 1 diabetes.
    Revert A; Garelli F; Pico J; De Battista H; Rossetti P; Vehi J; Bondia J
    IEEE Trans Biomed Eng; 2013 Aug; 60(8):2113-22. PubMed ID: 23428611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a fully automated closed loop artificial pancreas control system with dual pump delivery of insulin and glucagon.
    Jacobs PG; El Youssef J; Castle JR; Engle JM; Branigan DL; Johnson P; Massoud R; Kamath A; Ward WK
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():397-400. PubMed ID: 22254332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial pancreas: an emerging approach to treat Type 1 diabetes.
    Kumareswaran K; Evans ML; Hovorka R
    Expert Rev Med Devices; 2009 Jul; 6(4):401-10. PubMed ID: 19572795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes.
    Tauschmann M; Hovorka R
    Expert Opin Drug Deliv; 2017 Dec; 14(12):1367-1377. PubMed ID: 28819992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of SmartGuard Technology in the Prevention of Nocturnal Hypoglycemia After Prolonged Physical Activity.
    Petruzelkova L; Pickova K; Sumnik Z; Soupal J; Obermannova B
    Diabetes Technol Ther; 2017 May; 19(5):299-304. PubMed ID: 28520532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems.
    Tauschmann M; Hovorka R
    Expert Opin Drug Deliv; 2014 Jun; 11(6):943-55. PubMed ID: 24749563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A semiclosed-loop optimal control system for blood glucose level in diabetics.
    Ibbini MS; Masadeh MA; Amer MM
    J Med Eng Technol; 2004; 28(5):189-96. PubMed ID: 15370997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress of artificial pancreas devices towards clinical use: the first outpatient studies.
    Russell SJ
    Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):106-11. PubMed ID: 25692927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of technology to reduce hypoglycemia.
    Choudhary P; Amiel SA
    Pediatr Endocrinol Rev; 2010 Aug; 7 Suppl 3():384-95. PubMed ID: 20877251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural network modeling and control of type 1 diabetes mellitus.
    El-Jabali AK
    Bioprocess Biosyst Eng; 2005 Apr; 27(2):75-9. PubMed ID: 15578231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided continuous drug infusion: setup and test of a mobile closed-loop system for the continuous automated infusion of insulin.
    Dudde R; Vering T; Piechotta G; Hintsche R
    IEEE Trans Inf Technol Biomed; 2006 Apr; 10(2):395-402. PubMed ID: 16617628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fuzzy logic based closed-loop control system for blood glucose level regulation in diabetics.
    Ibbini MS; Masadeh MA
    J Med Eng Technol; 2005; 29(2):64-9. PubMed ID: 15804854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closing the loop: the adicol experience.
    Hovorka R; Chassin LJ; Wilinska ME; Canonico V; Akwi JA; Federici MO; Massi-Benedetti M; Hutzli I; Zaugg C; Kaufmann H; Both M; Vering T; Schaller HC; Schaupp L; Bodenlenz M; Pieber TR
    Diabetes Technol Ther; 2004 Jun; 6(3):307-18. PubMed ID: 15198833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New technologies in the treatment of type 1 diabetes.
    Schmidt S
    Dan Med J; 2013 Nov; 60(11):B4746. PubMed ID: 24192247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.